Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography

Kim, Bomi; Park, Yoonseon; Kim, Min Jung; Lee, Seung Hyun

doi:10.1016/j.clinimag.2021.05.031

Cited by 9 publications

(21 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Around one dozen articles review the phenomenon and updated clinical guidelines. 15 , 17 , 19 , 20 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 31 , 32 , 33 , 34 , 38 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 ,…”

Section: Discussion With Review Of Literatureunclassified

COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature

Lim

Lee

Khil

et al. 2021

Seminars in Oncology

View full text Add to dashboard Cite

Purpose – Lymphadenopathy (LAP) after COVID-19 vaccination in patients with a diagnosis of cancer has been challenging. We analyzed imaging and clinical features from early cases of axillary LAP in six COVID-19 vaccine recipients with a history of breast cancer. Method – Among the patients with a history of breast cancer and recent COVID-19 vaccine administration, six patients who showed isolated axillary LAP were gathered. Radiologic features were reviewed from breast ultrasound, chest computed tomography, and breast magnetic resonance imaging. Clinical and pathological information were obtained for analysis. Results – The interval between ultrasound detection of LAP and last COVID-19 vaccine administration ranged from 14 to 28 days (mean 21.67 days). Round shape of the lymph node and irregular cortex were noted in two and zero cases, respectively. Mean maximum cortical thickness, length to width ratio and interval aggravation in maximum cortical thickening were 4.2 mm, 1.34 and 2.81-fold with cut-off value of 3 mm, 1.5, 2.0-fold, respectively. Conclusion – We observed axillary LAP ipsilateral to a recent vaccine administration persisting longer than what the Centers for Disease Control and Prevention announced. In our patients, COVID-19 vaccine related LAP tended to show increased cortical thickness without cortical irregularity. Oncologist as well as radiologist should be familiar with the fact that COVID-19 vaccines, regardless of vaccine type or dosage, can frequently cause ipsilateral axillary LAP, showing some suspicious features more often than others, and can persist longer than anticipated so that both over- and underdiagnosis can be avoided. We report our observations in six patients and provide an exhaustive review of the published literature

show abstract

Section: Discussion With Review Of Literatureunclassified

COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature

Lim

Lee

Khil

et al. 2021

Seminars in Oncology

View full text Add to dashboard Cite

show abstract

“…Reações locais Dor, rubor, edema, eritema. Beatty et al, 2021;Burlando et al, 2022;Catala et al, 2021;Chapin-Bardales et al, 2021;Dziedzic et al, 2021;Kitagawa et al, 2021;Klugar et al,2021;Pourani et al, 2021;Park et al, 2021;Patel et al, 2021;Riad et al, 2021ª;Riad et al, 2021c.…”

Section: Vacina Modernamentioning

confidence: 99%

“…2021) e o exantema intertriginoso e flexural(SDRIFE) (Hai et al, 2021), reações oftalmológicas como retinopatia serosa e oclusão de veia retiniana de ramo(ORVR) (Fowler et al 2021) Em relação ao sexo a maior incidência de reações adversas ocorrem em pessoas do sexo feminino (Alghamdi et al 2021;Almohaya et al 2021;Javed et al 2021;Kitagawa et al 2021;Klugar et al 2021;Mcmahon et al 2021;Omeish et al 2021;Riad et al 2021;Saita et al 2021;Vigezzi et al 2021). Entre as reações adversas graves que constam na pesquisa, quatro delas são pacientes do sexo feminino (Ahmad et al 2021;Cieslewicz et al 2021;Hai et al 2021;Kim et al 2021;Mira et al 2021), e uma reação adversa fatal (Ameratunga et al 2021).…”

Section: Vacina Sinopharmunclassified

Reações adversas pós-vacinação por COVID-19: uma revisão integrativa

Correa¹,

Pereira²,

Luz

et al. 2022

RSD

View full text Add to dashboard Cite

Objetivo: Identificar na literatura as principais reações adversas das vacinas contra o COVID-19. Metodologia: Revisão integrativa, conduzida nas estratégias de busca Biblioteca Virtual em Saúde (BVS), Scopus (Elsevier) e Embase. Por meio da seguinte questão de pesquisa: “Quais reações adversas foram evidenciadas na literatura em pacientes vacinados por COVID-19?”. Utilizou-se o software RAYYAN® para importar os dados. Resultados: Identificou-se 1.816 estudos, destes, 57 contemplaram a revisão. Os resultados foram sintetizados em forma de tabela e verificou-se diversas reações classificadas em reações locais, sistêmicas e graves, constatou-se a maior incidência de reações adversas no sexo feminino e as manifestações foram imediatas a tardias. Conclusão: Foi evidenciado que a maioria das reações adversas pós-vacinação por COVID-19 foram locais, imediatas e autolimitadas. O enfermeiro deve promover ações para prevenir e identificar reações adversas pós vacinais.

show abstract

“…Vaccination against coronavirus disease 2019 (COVID-19) is currently being implemented across the world [1][2][3][4] . In order to end the global crisis caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, an intensive vaccination campaign is being carried out across the world to achieve herd immunity [1][2][3][4][5] . It is important for clinicians to recognize possible adverse reactions associated with COVID-19 vaccines in order to distinguish expected temporary reactions following vaccination from true pathological processes.…”

Section: Introductionmentioning

confidence: 99%

B-mode and Doppler ultrasonography patterns of axillary and supraclavicular lymphadenopathy associated with mRNA COVID-19 vaccine

Kaplanoğlu

Turan

et al. 2022

Cukurova Medical Journal

View full text Add to dashboard Cite

In this study, we present the ultrasound imaging features of lymph nodes arising in the regional lymph node chain after the first or second dose of the Pfizer-BioNTech COVID-19 vaccine. Ipsilateral lymphadenopathy adjacent to the vaccine injection site is an extremely rare but expected adverse reaction following COVID-19 vaccination. Although axillary lymphadenopathy is more common, cases of supraclavicular lymphadenopathy have also been reported after widespread vaccination against COVID-19. Ultrasonography examinations were performed on seven patients with no previous pathological conditions, who presented to our radiology department after receiving the Pfizer-BioNTech COVID-19 vaccine. Bilateral axillary, supraclavicular and subclavicular lymph node stations were explored. These patients typically present with enlarged hypoechoic lymph nodes with the loss of fatty hilum, asymmetric or diffuse cortical thickening, and increased hilar and cortical vascularization on the color doppler ultrasonography of the ipsilateral axillary and supraclavicular regions. Radiologists and clinicians should be aware of the ultrasonographic features of these lymph nodes and should inform the patient that these lymph nodes are often a self-limiting process. Thus, unnecessary axillary lymph node biopsies should be avoided, and patients should be treated conservatively.

show abstract

Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography

Cited by 9 publications

References 10 publications

COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature

COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature

Reações adversas pós-vacinação por COVID-19: uma revisão integrativa

B-mode and Doppler ultrasonography patterns of axillary and supraclavicular lymphadenopathy associated with mRNA COVID-19 vaccine

Contact Info

Product

Resources

About